Clinical Trials Logo

Filter by:
NCT ID: NCT01042249 Completed - Stroke Clinical Trials

Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke

Start date: February 2010
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of pelvic floor muscle training (PFMT) on Lower Urinary Tract Symptoms (LUTS) in men after stroke. 120 men with LUTS or increased LUTS after stroke is included and randomized into a treatment group or a control group. The subjects in the treatment group follows a 12 week standard PFMT program, while the control group is not given specific treatment of their LUTS but like the treatment group follows the standard rehabilitation program for stroke patient. Outcome are measured by - 5 questionnaires - Voiding diary - 24-hour pad test - pelvic floor muscle assessment test

NCT ID: NCT01042236 Completed - Clinical trials for Stress Urinary Incontinence

Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients

Start date: January 2009
Phase: Phase 2
Study type: Interventional

The hypothesis under evaluation is that fesotorodine may provide clinical benefit in the treatment of the condition of stress urinary incontinence

NCT ID: NCT01042197 Completed - Vitamin D Status Clinical Trials

The Relation Between Vitamin D Production and UVB Exposed Body Surface Area

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the relation between vitamin D production after UVB and exposed body surface areas with different UVB doses.

NCT ID: NCT01041404 Completed - Gastric Cancer Clinical Trials

ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer

Start date: September 2005
Phase: Phase 3
Study type: Interventional

This parallel, randomized, open-label, multi-centre study will evaluate the effect on overall survival of trastuzumab (Herceptin) in combination with a chemotherapy compared to the chemotherapy alone in patients with HER2-positive advanced gastric cancer. Trastuzumab (Herceptin) will be administered as intravenous infusion of 6 mg/kg (loading dose 8 mg/kg) every 3 weeks. The chemotherapy consists of a combination of 6 cycles of fluorouracil (800 mg/m2/day intravenous infusion every 3 weeks) and cisplatin (80 mg/m2 intravenous infusion every 3 weeks), or capecitabine (Xeloda, 1000 mg/m2 po twice daily for 14 days every 3 weeks) and cisplatin (80 mg/m2 intravenous infusion every 3 weeks). Treatment with trastuzumab (Herceptin) will continue until disease progression. The target sample size is 300-600 patients.

NCT ID: NCT01041352 Completed - Anaesthesia Clinical Trials

Laryngeal Mask or Endotracheal Tube for Back Surgery in the Prone Position

Start date: October 2009
Phase: N/A
Study type: Interventional

The aim of the study is to compare anaesthesia (for back surgery) using endotracheal intubation (patients anaesthized in the supine position)with anaesthesia using a laryngeal mask (anaesthesia induced and the laryngeal mask placed with the patient in the prone position on the operation table) as regards advantages, adverse effects and time spent. The anaesthesia in the 2 groups of patients is identical (propofol, remifentanil, rocuronium). Two groups of 70 pt. each are included in the stud. The inclusion criterias are patients 18-70 yrs., ASA group 1-2, normal airways, patients scheduled for back surgery with an estimated duration of less than 2 hours. Adverse effects (related to the placement on the operation table i.e. pain in the arms or shoulders, pain in the throat, blood in the sputum, irritation in the eyes etc.) and time spent with all the procedures (anaesthesia, placement of the airway, surgery and emergence from the anaesthesia are registered. The hypothesis is that the method using the laryngeal mask is faster and with fewer adverse effects.

NCT ID: NCT01040689 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.

NCT ID: NCT01040234 Completed - Postoperative Pain Clinical Trials

Bilateral Dual TAP Block: Description of a Novel Four-point Approach

Start date: November 2009
Phase: Phase 4
Study type: Observational

A prospective study of 30 patients with severe postoperative pain following abdominal surgery, in which the dual TAP block technique has been used successfully to achieve pain relief. A description of ultrasound technique, effectiveness, duration and potential side effects of the pain treatment, with possible recommendations for future use.

NCT ID: NCT01039337 Completed - Osteoarthritis, Hip Clinical Trials

Conservative Treatment for Hip Osteoarthritis

COHART
Start date: October 2008
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effect of manual treatment and a patient education programme for patients without indication for hip surgery.

NCT ID: NCT01038180 Completed - Bradycardia Clinical Trials

Complications Following Pacemaker Implantation

Start date: January 1997
Phase: N/A
Study type: Observational

This study examines possible risk factors with regard to complications following pacemaker implantation.

NCT ID: NCT01037647 Completed - Type 2 Diabetes Clinical Trials

VLDL-triglyceride Kinetics in Type 2 Diabetes

Start date: May 2008
Phase: N/A
Study type: Observational

Type 2 diabetes is associated with diabetic dyslipidemia, which is a major risk factor for coronary heart disease. Triglycerides (TG) and cholesterol are transported in the system of lipoproteins, and the metabolism of these lipids in plasma is closely interrelated. Evidence suggests that increased concentration of very low-density lipoprotein triglyceride (VLDL-TG) is a central pathophysiological feature of the lipid and lipoprotein abnormalities in diabetic dyslipidemia. The objective of this study was to investigate VLDL-TG kinetics and aspects of peripheral VLDL-TG metabolism, i.e. to what extent VLDL-TG associated fatty acids (FA) are oxidized or deposited in regional adipose tissue, in subjects with type 2 diabetes and healthy controls in the postabsorptive state and during acute hyperinsulinemia using ex-vivo labeled VLDL-TG tracers.